Howard Hughes Medical Institute’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89K | Buy |
+31
| New | +$3.89K | ﹤0.01% | 379 |
|
|
2017
Q3 | – | Sell |
-1,150
| Closed | -$312K | – | 43 |
|
|
2017
Q2 | $312K | Sell |
1,150
-2,247
| -66% | -$610K | 0.06% | 110 |
|
|
2017
Q1 | $929K | Sell |
3,397
-332
| -9% | -$90.8K | 0.17% | 74 |
|
|
2016
Q4 | $1.06M | Sell |
3,729
-792
| -18% | -$224K | 0.24% | 69 |
|
|
2016
Q3 | $1.42M | Buy |
4,521
+4,171
| +1,192% | +$1.31M | 0.36% | 58 |
|
|
2016
Q2 | $85K | Sell |
350
-167
| -32% | -$40.6K | 0.03% | 134 |
|
|
2016
Q1 | $135K | Buy |
+517
| New | +$135K | 0.03% | 126 |
|
|
2015
Q4 | – | Sell |
-696
| Closed | -$203K | – | 171 |
|
|
2015
Q3 | $203K | Buy |
+696
| New | +$203K | 0.04% | 120 |
|
|
2014
Q3 | – | Sell |
-143
| Closed | -$45K | – | 180 |
|
|
2014
Q2 | $45K | Buy |
+143
| New | +$45K | 0.01% | 145 |
|